These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 12618252

  • 1. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability.
    Novák A, de la Loge C, Abetz L, van der Meulen EA.
    Contraception; 2003 Mar; 67(3):187-94. PubMed ID: 12618252
    [Abstract] [Full Text] [Related]

  • 2. High acceptability and satisfaction with NuvaRing use.
    Szarewski A.
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():31-6; discussion 37-9. PubMed ID: 12659400
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring.
    Dieben TO, Roumen FJ, Apter D.
    Obstet Gynecol; 2002 Sep; 100(3):585-93. PubMed ID: 12220783
    [Abstract] [Full Text] [Related]

  • 5. Lower hormone dosage with improved cycle control.
    Vree M.
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():25-30; discussion 37-9. PubMed ID: 12659399
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.
    Verhoeven CH, Dieben TO.
    Contraception; 2004 Mar; 69(3):197-9. PubMed ID: 14969666
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
    Weisberg E, Fraser IS, Mishell DR, Lacarra M, Darney P, Jackanicz TM.
    Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484
    [Abstract] [Full Text] [Related]

  • 11. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition.
    Mulders TM, Dieben TO.
    Fertil Steril; 2001 May; 75(5):865-70. PubMed ID: 11334895
    [Abstract] [Full Text] [Related]

  • 12. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM, de Souza JC, da Silva AR, de Acosta OM, Alvarez F, Brache V, Garza Flores J, Vasquez-Estrada L, Santo R, Bassol S.
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [Abstract] [Full Text] [Related]

  • 13. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
    Weisberg E, Fraser IS, Lacarra M, Mishell DR, Alvarez F, Brache V, Nash HA.
    Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development and validation of an acceptability and satisfaction questionnaire for a contraceptive vaginal ring, NuvaRing.
    Novák A, de la Loge C, Abetz L.
    Pharmacoeconomics; 2004 May; 22(4):245-56. PubMed ID: 14974874
    [Abstract] [Full Text] [Related]

  • 16. Vaginal ring contraception.
    Kerns J, Darney P.
    Contraception; 2011 Feb; 83(2):107-15. PubMed ID: 21237335
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol.
    Bjarnadóttir RI, Tuppurainen M, Killick SR.
    Am J Obstet Gynecol; 2002 Mar; 186(3):389-95. PubMed ID: 11904596
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.